Osteogenesis Imperfecta Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2005
NCT00131469
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now